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When William Trager was in high school in Newark, New
Jersey, the caterpillars he collected sometimes hatched Out
parasitic flies instead of butterflies. "Another collector would
have been disappointed, but I was fascinated," he recalls. "I
guess I just always have liked parasites more than most peo-
ple do."
Professor Trager, head of the parasitology laboratory of
The Rockefeller University, is one of the world's leading
authorities on parasitic protozoa. In the ranks of these single-
celled organisms, transmitted to host organisms by interme-
diary carriers such as insects, are the agents responsible for
the largest number of debilitating or deadly diseases on earth,
foremost among them malaria. Last spring, Dr. Trager flew to
Geneva to accept the Samuel Taylor Darling medal of the
World Health Organizarion for his contriburions to malaria
research. If a vaccine is developed for malaria, and he is con-
fident one soon will be, his work will have been the caralyst.
Four years ago, Dr. Trager and an associate, Dr. James B.
Jensen, reponed the first continuous cultivation in a rest tube
of Plasmodium /alciparum, the most lethal of the four species
of malaria parasites that infect human beings. In the past, the
lack of a means to cultivate the malaria parasite outside of a
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living host has been the major roadblock to making an effec-
tive vaccine. The achievement was likened to the discovery
by Harvard researchers years ago that polio virus could be
grown in tissue culture-the scientific breakthrough that led
to a polio vaccine.
For basic scientists, asking questions about the processes of
natural phenomena is the main job. When Dr. Trager first
began studying malaria parasites, his object was not to find a
vaccine, which was generally considered unfeasible~
"My primary interest," he says, "was in the physiology and
biochemistry of parasitism. I chose to work with malaria para-
sites, among others, because I thought they would provide
good material for basic studies of the interactions between
parasites and their hosts, something we still don't know a lot
about. For example, the malaria parasite grows inside the red
blood cell of its host. Why does it have to live in a red cell?
What does it get out of rhe cell? How does ir affecr the cell?
How does rhe parasire interfere wirh rhe hosr's development
of immunity? How does the host manage to survive, when ir
does survive?"
A practical solution was assumed to have been found to
malaria as a health problem in the years following World War
II. Conrrol of malaria mosquitoes was achieved in many areas
through the use of powerful insecticides like DDT. In India,
for example, malaria cases dropped from 100 million in 1952
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to 60 thousand in 1962. However, total eradication was never
achieved and, in the decade that followed, malaria mosquitOes
in large stretches of the tropical world began acquiring immu-
nity to the insecticides. As spraying became less effective and
more expensive, control programs were abandoned and
malaria resurfaced as a major problem for global health. The
world estimate of current cases is between 200 and 300 mil-
lion. In Africa alone, at least one million children die of
malaria every year. To compound the tragedy, malaria para-
sites in many areas have become resistant to present day anti-
malarial drugs.
One reason a successful malaria vaccine has never been
developed is that a single exposure to malaria, unlike the case
in some other diseases, does not produce long-term immu-
nity. Recent findings indicate that it might be possible to
induce longer immunity if the antigenic material-the sub-
stance produced by the parasite that triggers the body's
immune response-could be administered in more concen-
trated amounts than are ordinarily produced in victims of the
naturally-occurring disease. But what substance? Adminis-
tered at what point in the disease cycle? In what dosage?
These questions could nor begin to be answered without a
reliable method for cultivating the malaria parasites. As Dr.
Trager succinctly states: "By the early 1970s, we knew we had
to figure out how to grow the damned things."
Dr. Trager is a longtime master of laboratory culture tech-
niques. More than 40 years ago, he achieved the first insect
tissue culture, in which he grew viruses, and tackled another
vexing problem: do insect-transmitted viruses multiply in the
insect as well as the vertebrate hose. To determine that they
did meant getting absolutely uncontaminated mosquito tissue
to culture, a considerable feat in the days before antibiotics.
He has also worked extensively with trypanosome parasites.
In 1974, he developed a new method for cultivating one of
the principal agents of cattle trypanosomiasis, a disease that
decimates food herds in Africa.
Because, in the past, he wanted mostly to study nutrition
and physiology in malaria parasites, he worked at culturing
them outside the red cells, which turned out to be an extre-
mely difficult and- tedious process. He did have some success
with a species of bird malaria and, among his findings, he
established the first direct evidence of the significance of
nutritional factors in host susceptibility to the disease. Studies
of human malaria, however, were limited for many years by
the lack of a suitable experimental animal. Chimpanzees
could be infected, but worki'ng with them was cumbersome
and expensive. Then, in 1968, it was discovered that some
strains of human falciparum malaria could be grown in a small
South American monkey, thereby providing a more accessi-
ble source of infectious material. This greatly aided research,
especially when vaccine development again came under
consideration.
A REASONABLE IDEA
"When I began working to get an intracellular culture [a cul-
ture kept alive inside red cells but outside the host animal], I
was sure I'd have a long, hard road ahead," says Dr. Trager.
To keep the parasites alive required determining and main-
taining the right balance of red blood cells, serum, culture
medium, carbon dioxide, oxygen, and temperature. "Quite a
number of people had tried and failed, going back to around
1912 or so. But 1 thought 1 had a reasonable idea." Reason-
able and, as it turned out, right.
As Dr. Trager describes it, his reasonable idea was based on
"letting the red cells stay quiet instead of agitating them and
having some way of providing di.em, at the same time, with a
change in medium." The method he employed was to have a
shallow stationary layer of red blood cells, within a laboratory
vessel, covered by a shallow layer of medium that flowed
slowly and continuously over the settled cells. The culture
was maintained at a constant temperature and under an atmo-
sphere containing fixed percentages of carbon dioxide and
oxygen. Shortly after Dr. Trager got the first successful
experiment going, James Jensen joined the lab and helped
refine the technique. The cultures are easy to prepare with
simple equipment, a real benefit in areas where trained tech-
nicians and research funds are in short supply, and Dr. Trager
and his colleagues have traveled around the world teaching
the method.
"I suppose you could say that we brought human malaria
into the laboratory really for the first time," explains Dr.
Trager. "What the cultivation has done is to permit the
domestication of the parasite, so to speak. 1 won't say we've
tamed it,. not yet, but we do finally have it available. In the
past, we could draw out some peripheral blood from infected
animals and look at the early stages of the disease, but we had
to kill the animals and remove the organs to get any picture of
the later stages, and what we got was a very incomplete pic-
ture. Now we can look at the intracellular stages in action. We
can begin to discern fine structures and see things we didn't
know were there."
In the life cycle of malaria parasites, forms called sporo-
zoites, transmitted through the bite of the female Anopheles
mosquito to the host, localize in the host's liver where they
develop into merozoites. These break out of the liver cells
and invade the red blood cells, where they keep dividing and
infecting other blood cells, producing the symptoms of dis-
ease. Some merozoites go on to develop into gametocytes. If
the host is bitten again by a mosquito at this stage, the game-
tocytes pass into the mosquito's stomach and produce new
sporozoites that migrate to the mosquito's salivary glands and
the cyle starts again.
One way of making a vaccine is to use whole organisms.
This cultivation method has opened the way for harvesting
merozoites in quantity, a prerequisite for producing a vac-
cine, and a merozoite vaccine has already been tried on mon-
keys with good results. To make a vaccine that is acceptable
for human use, however, it is 'necessary to find a way of free-
ing the merozoites from the red cell material. This material
can have extremely toxic side effects. It is also necessary to
prolong immunity through the use of chemical boosters
called adjuvants. Adjuvants are used in some vaccines for
other diseases, but no safe malaria adjuvant has yet been dis-
covered. Another possible approach is to find and use specific
antigenic substances within the merozoite. Last spring, Dr.
Araxie Kilejian of Dr. Trager's group, working with the cul-
ture method, reported that she had isolated a series of pro-
teins among which may be the antigens that stimulate
immunity.
THE KNOB STORY
The culture method has also figured in an ongoing mystery
that Dr. Trager calls the knob story, which began in 1966
when he and Dr. Maria A. Rudzinska studied under the elec-
tron microscope some infectious malarial material he had
brought back from Liberia. Dr. Rudzinska, a member of the
Trager lab for 24 years, was one of the first researchers to





human red blood cell infected
with the malaria parasite
, Plasmodium falciparum. The
surface ofthe blood cell is
distorted as a result ofthe
infection and bears dense
protrusions, the knobs. X13,OOO
Page 4
Dr. Kilejian
RESEARCH PROFILES is pub-
lished four times a year by The
Rockefeller University. It is writ-
ten and edited by Fulvio Bardossi
and Judith N. Schwartz. This is
issue Number 2, Fall 1980. Inquir-
ies should be addressed to the Uni-
versity's Public Information
Office, 1230 York Avenue, New
York 10021, or phone (212) 360-
1261. Photographs, Ingberr
Griittner. Electron micrograph,
page 3, Dr. Susan Langreth. ©The
Rockefeller University. Primed in
the United States of America.
Reprint 1980 November
"We found that the infected cells had little knoblike pro-
trusions on their surface. We didn't know what to make of
them. About the same time, we were studying a form of mon-
key malaria that behaves very much like human falciparum
malaria and we found the knobs again, in cells with large para-
sites in them; when the parasites were small, at a younger
stage of their development, the red cells had no knobs. We
suggested that the knobs might be points at which infected
cells attach themselves to the capillary endothelium, the
membranous covering of the capillaries. That hunch later
proved to be right. But that's where the story stood, until we
got the parasites in test tubes.
"After we had been culturing a line of cells for about a year
and a half, Dr. Susan Langreth, who was following and record-
ing the c-ulture with the electron microscope, noticed that the
knobby cells had lost their knobs. Subsequently, the same
thing has happened with every batch of cells after about the
same amount of time. We don't know why. Are the knobless
cells a mutant form? ,Are they the result of culture condi-
tions? Are they still infective? Are they an attenuated line?
An attenuated line might be used to produce a live vaccine.
"We won't be able to answer those questions until we can
isolate and clone an absolutely pure knobless line, and that's
presenting some tricky technical problems. Meanwhile, the
knobs have helped Dr. Kilejian. She has found a prote.in in
the knobby cells that is not present in the knobless ones and
seems to be very similar to a protein she had previously iso-
lated for duck malaria. If it's an immunogenic protein, then it
might be a bet for a vaccine. A number of laboratories else-
where have now taken up work on this knobless business."
A SPUR TO NEW RESEARCH
Beyond the search for a vaccine, the culture method has
opened the way to other important work. As Dr. Trager
points out, "It has proven to be the most efficient and eco-
nomical tool for screening new antimalarial drugs and for
learning how these drugs work. It has been the means
through which we have learned how certain red cell abnor-
malities such as sickle-cell anemia confer relative resistance to
falciparum malaria. With it, we are beginning to understand
the factors that promote formation of gametocytes. Perhaps
most exciting from a scientist's viewpoint, we are using cul-
tures to study genetic variation; in other words, we're getting
right into the parasite's DNA."
There is a renewed vigor in parasitology research, spurred
largely by the urgency of the malaria crisis which has helped
to focus the attention of the world health community on the
magnitude of the overall problem in the Third World, where
parasite-borne diseases take a staggering toll in human life
and productivity. Malaria is the big emphasis, of course, but
Dr. Trager's success with his culture method has had a stimu-
lating effect in getting people to try again to culture other
organisms. Within a year of his announcement, the same
method with small modifications was used to make a vaccine
against a widespread cattle disease caused by parasites that,
like malaria, infect red blood cells.
Today, scientists from a variety of disciplines working with
new tools and techniques, are looking at parasites from many
view points. At The Rockefeller, for example, they are being
studied in laboratories of cell biology, immunology, and med-
ical biochemistry. .
For Dr. Trager, this year celebrating his 70th birthday and
his 47th year at the University, the goals remain essentially
the same. "I was interested in physiology and biochemistry.
Th~t's what I've mostly studied and what I'm still studying. I
remember once, years ago, having a chat with Dr. Gasser
[Herbert Gasser, Nobel laureate and director of The Rock-
efeller from 1935 to 1953]. He was very interested in what I
was trying to do then with parasite cultivation, but he wasn't
worrying specifically about whether it would have practical
results. I'm sure he thought it would be nice if it did, but the
idea, really, was just to do good work." 0
